New Advancements from Ambion in Data Analysis for MicroRNA Profiling
News Feb 21, 2006
Ambion Services has announced the release of an expression profiling service specifically for microRNA analysis that surpasses any other offering currently in the market.
A growing body of evidence suggests that microRNAs could be useful in diagnosis and treatment for a range of diseases.
Based on technology from Ambion, expression profiles generated from this service are sensitive and representative of the microRNAs present in samples.
Ambion Services has further advanced this technology, developing proprietary algorithms for data normalization and scaling that are key to delivering meaningful expression information.
Ambion Services tailored their comprehensive data analysis algorithms and statistical approaches for microRNA profiling because many of the fundamental assumptions used for messengerRNA analysis do not apply.
According to Scott Hunicke-Smith, Ph.D., Vice President of Ambion Services, "One cannot rely on mRNA expression profiling experience when performing microRNA profiling data analysis."
"We have focused our development efforts, utilizing Ambion's extensive database of microRNA expression data, on the unique tools required for miRNA analysis."
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE
Cell Types Underlying Schizophrenia IdentifiedNews
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.READ MORE